MedPath
HSA Approval

LISORIL 5 TABLET 5 mg

SIN07868P

LISORIL 5 TABLET 5 mg

LISORIL 5 TABLET 5 mg

October 6, 1994

ZYFAS PHARMA PTE LTD

ZYFAS PHARMA PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantZYFAS PHARMA PTE LTD
Licence HolderZYFAS PHARMA PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

C09AA03

lisinopril

Manufacturer Information

ZYFAS PHARMA PTE. LTD.

IPCA LABORATORIES LTD

Active Ingredients

LISINOPRIL EQV LISINOPRIL (ANHYDROUS)

5 mg

Lisinopril

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

LISORIL 5 TABLET 5 mg - HSA Approval | MedPath